STRATA Skin Sciences (SSKN) Gains from Investment Securities (2013 - 2025)

STRATA Skin Sciences has disclosed Gains from Investment Securities across 13 years of filings, most recently posting $83000.0 for Q4 2025.

• Gains from Investment Securities for Q4 2025 came in at $83000.0, up 854.55% year-over-year; the trailing twelve-month figure through Dec 2025 was $81000.0 (up 4150.0% YoY), and the FY2025 annual result was $34000.0, down 93.48% from the prior year.
• Gains from Investment Securities came in at $83000.0 for Q4 2025 at STRATA Skin Sciences, up from $16576.0 in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $7.3 million in Q3 2024 to a low of -$13000.0 in Q1 2024.
• The 5-year median for Gains from Investment Securities is $1.5 million (2021), against an average of $2.9 million.
• Across the five-year window, Gains from Investment Securities soared 19075.5% in 2023 and plunged 150.0% in 2024, its largest moves.
• STRATA Skin Sciences' Gains from Investment Securities stood at $73000.0 in 2021, then surged by 6125.64% to $4.5 million in 2022, then tumbled by 99.52% to $22000.0 in 2023, then slumped by 150.0% to -$11000.0 in 2024, then jumped by 854.55% to $83000.0 in 2025.
• The last three Gains from Investment Securities figures came in at $83000.0 (Q4 2025), $16576.0 (Q3 2025), and -$11000.0 (Q4 2024), per Business Quant data.